Protenus

The company's core business revolves around its Patient Privacy Monitoring and Drug Diversion Surveillance platform. This platform helps hospitals and health systems protect sensitive patient data and prevent the theft of controlled substances. Protenus serves a client base of healthcare organizations, offering them tools to ensure compliance with regulations like HIPAA and to combat the growing issue of drug diversion within their facilities. The business model is based on providing these risk-reduction solutions as a service, presumably through a subscription or licensing fee structure. The platform analyzes every access to patient data within a hospital's electronic health record system, using AI to identify inappropriate access patterns. For drug diversion, the system scrutinizes the entire medication lifecycle—from procurement to administration—to detect suspicious activities that could indicate theft for personal use or sale.

Protenus has achieved several key milestones, including securing multiple rounds of funding to fuel its growth and product development. For instance, the company raised $21 million in a Series D funding round in 2021, bringing its total funding to over $50 million at the time. Throughout its history, Protenus has garnered industry recognition, being named to various prestigious lists such as the Forbes list of America's Best Startup Employers and Modern Healthcare's Best Places to Work. Keywords: healthcare AI, patient privacy monitoring, drug diversion surveillance, healthcare compliance, risk reduction, electronic health records, data security, health data analytics, HIPAA, controlled substances